Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
CareCloud ( (CCLD) ) has shared an update.
CareCloud announced its inclusion in the Russell Microcap Index as of June 30, 2025, following a 70% rise in its common stock price during the second quarter of 2025. This milestone highlights the company’s growing momentum in the healthcare technology sector, driven by strategic initiatives such as launching an AI Center of Excellence, resuming acquisition activities, and maintaining a strong cash position.
The most recent analyst rating on (CCLD) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on CareCloud stock, see the CCLD Stock Forecast page.
Spark’s Take on CCLD Stock
According to Spark, TipRanks’ AI Analyst, CCLD is a Neutral.
CareCloud’s strong financial recovery and positive earnings call are major strengths, indicating effective management and strategic focus on growth through AI and acquisitions. However, technical indicators suggest caution due to potential overbought conditions, and valuation remains a concern due to negative P/E ratios.
To see Spark’s full report on CCLD stock, click here.
More about CareCloud
CareCloud is a leader in AI-driven healthcare technology solutions, offering a suite of products that enhance financial and operational performance, streamline clinical workflows, and improve patient experiences. Serving over 40,000 providers, CareCloud’s offerings include revenue cycle management, practice management, electronic health records, business intelligence, patient experience management, and digital health solutions.
Average Trading Volume: 543,009
Technical Sentiment Signal: Sell
Current Market Cap: $96.07M
For a thorough assessment of CCLD stock, go to TipRanks’ Stock Analysis page.